Tactile Medical to Participate in Upcoming Investor Conferences in May

MINNEAPOLIS, April 20, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency, today announced that management will participate in the following investor conferences in May:

The Deutsche Bank 42nd Annual Health Care Conference at the InterContinental Hotel in Boston, MA

• Management will present on Thursday, May 4 at 9:20 a.m. Eastern Time.

The Bank of America Merrill Lynch 2017 Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV

• Management will present on Thursday, May 18 at 10:00 a.m. Pacific Time.

Live audio webcasts of the presentations will be accessible under the ‘Events & Webcasts' section of the Company's investor relations website at http://investors.tactilemedical.com. Archives of the webcasts will be available for replay following the conferences.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our efforts help increase clinical efficacy, reduce overall healthcare costs, and improve the quality of life for patients with chronic conditions.

Investor Inquiries:

Mike Piccinino, CFA
Managing Director
Westwicke Partners
443-213-0500
[email protected]